VALYSTR · Stock research
Listed on NasdaqCM. What the market is pricing into BioStem Technologies, Inc. (BSEM) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Biotechnology · market value about $20.5M · revenue $34.6M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows